Table 2.
Characteristics of HSRs to platinum agents and skin test results.
| Variation | CBDCA | CDDP | CBDCA/CDDP |
|---|---|---|---|
| Immediate n°/total HSR (%) | 42/44 (95) | 6/6 (100) | 8/8 (100) |
| -Positive skin tests n°/total immediate-HSR (%) | 27/42 (64) | 6/6 (100) | 8/8 (100) |
| -Negative skin tests n°/total immediate-HSR (%) | 15/42 (36) | 0/6 (0) | 0/8 (0) |
| Not anaphylaxis (grade 1 and 2) n/total immediate-HSR (%) | 17/42 (40) | 4/6 (67) | 3/8 (37) |
| Anaphylaxis (grades 3–5) n/total immediate-HSRs (%) | 25/42 (60) | 2/6 (33) | 5/8 (63) |
| Delayed n°/total HSR (%) | 2/44 (5) | 0 (0) | 0 (0) |
| -Positive skin tests n/total delayed-HSR (%) | 1/2 (50) | - | - |
| -Negative skin tests n/total delayed-HSR (%) | 1/2 (50) | - | - |
Abbreviations: HSRs, hypersensitivity reactions; SPT, skin prick tests; IDT, intradermal tests.